Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double〣lind, Randomized Controlled Trial

发表于 2026-9-14 17:43:11

期刊：Arthritis & Rheumatology

文献作者：Roy Fleischmann; Aileen L. Pangan; In〩o Song; Eduardo Mysler; Louis Bessette; Charles Peterfy; Patrick Durez; Andrew J. Ostor; Yihan Li; Yijie Zhou; Ahmed A. Othman; Mark C. Genovese

出版日期：2019-11-

DOI号：10.1002/art.41032

下载链接：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.41032

文献链接：https://doi.org/10.1002/art.41032

当前文献来源于 Wiley。

备注信息：

发表于 2026-9-14 17:43:12

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Wiley] Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double〣lind, Randomized Controlled Trial

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Wiley] Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double〣lind, Randomized Controlled Trial 一键复制